Clinitech Laboratory (BOM:544220) FCF Margin %: -17.40% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544220 Clinitech Laboratory Ltd BOM:544220
38 GF Score
Price ₹37.00
! 6 Warning Signs
View Full Analysis

What is Clinitech Laboratory FCF Margin %?

Clinitech Laboratory BOM:544220 -7.50% 38 FCF Margin % is -17.40% as of Mar. 2026. GuruFocus rates BOM:544220 with a GF Score™ of 38/100. The stock has 6 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Clinitech Laboratory ranks worse than 66.01% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Clinitech Laboratory's Free Cash Flow for the six months ended in Mar. 2026 was ₹-7.68 Mil. Clinitech Laboratory's Revenue for the six months ended in Mar. 2026 was ₹44.11 Mil. Therefore, Clinitech Laboratory's FCF Margin % for the quarter that ended in Mar. 2026 was -17.40%.

As of today, Clinitech Laboratory's current FCF Yield % is -19.16%.

The historical rank and industry rank for Clinitech Laboratory's FCF Margin % or its related term are showing as below:

BOM:544220' s FCF Margin % Range Over the Past 10 Years
Min: -38.86   Med: -12.9   Max: 15.24
Current: -17.05


During the past 6 years, the highest FCF Margin % of Clinitech Laboratory was 15.24%. The lowest was -38.86%. And the median was -12.90%.

BOM:544220's FCF Margin % is ranked worse than
66.01% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.68 vs BOM:544220: -17.05


Clinitech Laboratory FCF Margin % Related Terms


Clinitech Laboratory FCF Margin % Historical Data

* Premium members only.

The historical data trend for Clinitech Laboratory's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinitech Laboratory FCF Margin % Chart

Clinitech Laboratory Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial -8.74 15.24 -38.86 -24.81 -17.05

Clinitech Laboratory Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only -54.56 -45.13 -4.90 -16.75 -17.40

BOM:544220 vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Clinitech Laboratory's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinitech Laboratory FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinitech Laboratory's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Clinitech Laboratory's FCF Margin % falls into.


BOM:544220
38GF Score
Clinitech Laboratory Ltd BOM:544220
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinitech Laboratory FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Clinitech Laboratory's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-16.184/94.912
=-17.05 %

Clinitech Laboratory's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-7.676/44.11
=-17.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -17.40% mean?
Clinitech Laboratory (BOM:544220) has a FCF Margin % of -17.40% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Clinitech Laboratory and its competitors. According to the industry distribution chart, Clinitech Laboratory ranks #134 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 66%.
Is Clinitech Laboratory's FCF Margin % too high?
Clinitech Laboratory's current FCF Margin % is -17.40%. Based on the distribution chart, Clinitech Laboratory ranks #134 out of 203 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Clinitech Laboratory has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Clinitech Laboratory's FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinitech Laboratory ranks #134 out of 203 companies for FCF Margin %. This places Clinitech Laboratory in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Clinitech Laboratory and its competitors. Clinitech Laboratory's current FCF Margin % is -17.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinitech Laboratory stock overvalued right now?
Clinitech Laboratory (BOM:544220) has a current FCF Margin % of -17.40%. The current FCF Margin % is -17.40%. Clinitech Laboratory's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Clinitech Laboratory (BOM:544220), the current FCF Margin % is -17.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clinitech Laboratory Business Description

Address AL-1/545 and 546, Sector 16, Opposite Radhikabai Meghe Vidyalaya, Airoli, Navi Mumbai, MH, IND, 400708
Clinitech Laboratory Ltd is an Indian diagnostic and healthcare services provider company. It operates a network of diagnostic centers in Thane and Navi Mumbai and offers various medical tests across multiple specialties, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology. It serves individual patients as well as corporate clients, aiming to provide affordable and comprehensive diagnostic solutions.
38GF Score

Get the complete analysis for BOM:544220

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.00
Price